Scarica l'app Stockscreener
58.01
4.43%
2.46
Dopo l'orario di chiusura:
58.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PTCT Giù?
Forum
Previsione
Precedente Chiudi:
$55.55
Aprire:
$55.65
Volume 24 ore:
1.90M
Relative Volume:
1.63
Capitalizzazione di mercato:
$4.61B
Reddito:
$900.66M
Utile/perdita netta:
$-453.20M
Rapporto P/E:
-9.766
EPS:
-5.94
Flusso di cassa netto:
$-274.19M
1 W Prestazione:
+16.51%
1M Prestazione:
+11.02%
6M Prestazione:
+11.99%
1 anno Prestazione:
+72.70%
Intervallo 1D:
$55.14
$58.05
Intervallo di 1 settimana:
$48.95
$58.05
Portata 52W:
$30.41
$58.38
Ptc Therapeutics Inc Stock (PTCT) Company Profile
Nome
Ptc Therapeutics Inc
Settore
Industria
Telefono
(908) 222-7000
Indirizzo
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ
Confronta PTCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PTCT
Ptc Therapeutics Inc
|
58.01 | 4.16B | 900.66M | -453.20M | -274.19M | -5.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ptc Therapeutics Inc Stock (PTCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Iniziato | Truist | Buy |
| 2025-05-09 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-05-07 | Aggiornamento | Citigroup | Sell → Neutral |
| 2025-03-11 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2025-03-07 | Iniziato | Scotiabank | Sector Perform |
| 2024-12-13 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-10-10 | Ripresa | Raymond James | Mkt Perform |
| 2024-09-04 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-26 | Ripresa | UBS | Buy |
| 2024-05-20 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2023-12-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-10-30 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-10-27 | Downgrade | Citigroup | Neutral → Sell |
| 2023-10-06 | Downgrade | Truist | Buy → Hold |
| 2023-09-18 | Downgrade | Citigroup | Buy → Neutral |
| 2023-09-15 | Downgrade | Raymond James | Outperform → Underperform |
| 2023-03-17 | Iniziato | SVB Securities | Market Perform |
| 2022-12-14 | Iniziato | Goldman | Sell |
| 2022-09-12 | Iniziato | Jefferies | Buy |
| 2022-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-09-01 | Iniziato | Citigroup | Buy |
| 2022-04-04 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-10-18 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-04-26 | Ripresa | Credit Suisse | Neutral |
| 2021-03-29 | Aggiornamento | RBC Capital Mkts | Underperform → Sector Perform |
| 2021-02-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-01-05 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-11-30 | Downgrade | RBC Capital Mkts | Sector Perform → Underperform |
| 2020-10-30 | Downgrade | Citigroup | Buy → Neutral |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-08-25 | Iniziato | Raymond James | Outperform |
| 2020-04-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-20 | Downgrade | Citigroup | Buy → Neutral |
| 2020-02-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-05-13 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-04-11 | Iniziato | Bernstein | Outperform |
| 2018-10-03 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2018-10-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-07-19 | Iniziato | Credit Suisse | Outperform |
| 2018-06-18 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-04-04 | Downgrade | Barclays | Equal Weight → Underweight |
| 2018-01-29 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2017-11-16 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2017-10-26 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2017-10-09 | Downgrade | JP Morgan | Neutral → Underweight |
Mostra tutto
Ptc Therapeutics Inc Borsa (PTCT) Ultime notizie
Russell Investments Group Ltd. Cuts Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics, Inc. $PTCT Shares Bought by Driehaus Capital Management LLC - MarketBeat
PTC Therapeutics: A Convergence of Strength in RS Rating, Catalysts, and Institutional Sentiment - AInvest
Combining price and volume data for PTC Therapeutics Inc.Dollar Strength & Community Driven Trade Alerts - Newser
Institutional scanner results for PTC Therapeutics Inc.July 2025 Closing Moves & AI Forecasted Stock Moves - Newser
Northern Trust Corp Increases Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Is PTC Therapeutics Inc. stock a good pick for beginnersJuly 2025 Fed Impact & Capital Protection Trade Alerts - khodrobank.com
Real time scanner hits for PTC Therapeutics Inc. explainedEarnings Beat & Risk Controlled Stock Alerts - Newser
RareMed Expands Partnership with PTC Therapeutics to Enhance Access to Sephience Therapy for PKU Patients - AInvest
Using economic indicators to assess PTC Therapeutics Inc. potentialJuly 2025 Weekly Recap & Weekly Momentum Picks - Newser
Technical analysis overview for PTC Therapeutics Inc. stockJuly 2025 Breakouts & AI Powered Market Trend Analysis - Newser
Best data tools to analyze PTC Therapeutics Inc. stock2025 Top Decliners & AI Based Buy and Sell Signals - Newser
Ieq Capital LLC Grows Stock Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
What institutional flow reveals about PTC Therapeutics Inc.Quarterly Trade Summary & Fast Moving Stock Watchlists - Newser
Is now a turning point for PTC Therapeutics Inc.Weekly Profit Analysis & AI Forecasted Stock Moves - Newser
Comparing PTC Therapeutics Inc. in custom built stock radarsMarket Weekly Review & Fast Moving Market Watchlists - Newser
Applying Wyckoff theory to PTC Therapeutics Inc. stockMarket Trend Summary & Fast Gain Swing Alerts - Newser
Heatmap analysis for PTC Therapeutics Inc. and competitorsJuly 2025 Selloffs & Low Drawdown Investment Strategies - Newser
Published on: 2025-09-03 02:23:46 - Newser
How cyclical is PTC Therapeutics Inc.’s revenue streamWeekly Profit Recap & Detailed Earnings Play Strategies - khodrobank.com
Earnings visualization tools for PTC Therapeutics Inc.Quarterly Portfolio Report & AI Enhanced Execution Alerts - Newser
Will PTC Therapeutics Inc. benefit from geopolitical trendsQuarterly Performance Summary & Reliable Price Breakout Alerts - khodrobank.com
What is PTC Therapeutics Inc.’s book value per shareJuly 2025 Macro Moves & Free Real-Time Volume Trigger Notifications - khodrobank.com
PTC Therapeutics, Inc. $PTCT Holdings Trimmed by Trexquant Investment LP - MarketBeat
PTC Therapeutics Inc. stock outlook for YEAR2025 Analyst Calls & AI Enhanced Trade Execution Alerts - Newser
PTC Therapeutics Director Allan Jacobson Sells 1667 Shares for $50.15 Each on 08/28/2025. - AInvest
Can PTC Therapeutics Inc. maintain its current growth rateJuly 2025 Decliners & AI Forecast for Swing Trade Picks - khodrobank.com
RareMed Solutions Expands Relationship with PTC Therapeutics - Contract Pharma
RareMed Expands Relationship with PTC Therapeutics for Sephience Therapy Launch - AInvest
RareMed Announces Expansion of Relationship with PTC Therapeutics - PR Newswire
PTC Therapeutics, Inc. $PTCT Shares Sold by Armistice Capital LLC - MarketBeat
Is it time to cut losses on PTC Therapeutics Inc.2025 Support & Resistance & Consistent Profit Alerts - Newser
What recovery options are there for PTC Therapeutics Inc.July 2025 Highlights & Consistent Growth Equity Picks - Newser
Smart tools for monitoring PTC Therapeutics Inc.’s price actionTrade Risk Report & Expert Approved Momentum Trade Ideas - Newser
Volatility clustering patterns for PTC Therapeutics Inc.Stop Loss & Weekly Top Stock Performers List - Newser
Key metrics from PTC Therapeutics Inc.’s quarterly data2025 Dividend Review & Fast Gaining Stock Strategy Reports - Newser
PTC Therapeutics, Inc. (PTCT) Faces FDA Setback on Vatiquinone for Friedreich’s Ataxia - MSN
Real time alert setup for PTC Therapeutics Inc. performancePortfolio Value Summary & AI Forecasted Entry and Exit Points - Newser
What is PTC Therapeutics Inc.’s valuation compared to sectorQuarterly Risk Review & Risk Controlled Stock Pick Alerts - khodrobank.com
Is PTC Therapeutics Inc. a stock for growth or value investorsJuly 2025 PreEarnings & AI Forecast Swing Trade Picks - khodrobank.com
PTC Therapeutics, Inc. $PTCT Shares Sold by Walleye Capital LLC - MarketBeat
Is PTC Therapeutics Inc. still worth holding after the dipVolume Spike & Short-Term Trading Alerts - Newser
Using Python tools to backtest PTC Therapeutics Inc. strategiesLong Setup & Daily Volume Surge Trade Alerts - Newser
Short Covering May Lift PTC Therapeutics Inc. in Near Term2025 Market Trends & Technical Pattern Alert System - beatles.ru
Using data models to predict PTC Therapeutics Inc. stock movementJuly 2025 Rallies & Target Return Focused Stock Picks - Newser
Rafferty Asset Management LLC Sells 20,965 Shares of PTC Therapeutics, Inc. $PTCT - MarketBeat
Is a relief rally coming for PTC Therapeutics Inc. holders2025 Market WrapUp & Scalable Portfolio Growth Ideas - Newser
Ptc Therapeutics Inc Azioni (PTCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):